期刊文献+

Tim-3在胃癌组织中的表达及其临床意义 被引量:8

Expression and clinical significance of Tim-3 in gastric cancer tissues
下载PDF
导出
摘要 目的研究T细胞免疫球蛋白及黏蛋白结构域分子3(Tim-3)在胃癌组织中的表达及其临床意义。方法采用流式细胞术检测52例胃癌及15例胃炎患者手术标本Tim-3的表达。结果 CD4+和CD8+T细胞均可见Tim-3的表达,胃癌组织CD4+T细胞Tim-3表达为(12.4±8.41)%,明显高于胃炎组的(6.01±1.95)%;胃癌组织CD8+T细胞中Tim-3表达为(9.56±7.48)%,明显高于胃炎组的(5.39±2.98)%,差异均有统计学意义(P<0.05)。Tim-3在CD4+T细胞中的表达与胃癌患者的浸润深度、淋巴结转移和TNM分期有关(P<0.05),而与性别、年龄、肿瘤大小、组织学类型均无关(P>0.05)。Tim-3在CD8+T细胞中的表达仅与胃癌患者的TNM分期有关(P<0.05),而与其他临床病理学特征均无关(P>0.05)。结论Tim-3在胃癌的侵袭、转移过程中可能起着重要作用,是胃癌患者的不良预后因素之一。 Objective To evaluate the expression of Tim-3 and its clinical significance in the gastric cancer tissues.Methods Fifty-two gastric cancer specimens and 15 gastritis tissues were detected for Tim-3 by flow cytometry,and 15 specimens of gastritis tissues served as the control.Results Tim-3 expressed both in gastric cancer tissues and gastritis tissues.In CD4+T cells,the expression level of Tim-3 in gastric cancer tissues(12.4±8.41)% was significantly higher than gastritis tissues(6.01±1.95)%;In CD8+T cells,the expression level of Tim-3 in gastric cancer tissues(9.56±7.48)% was significantly higher than gastritis tissues(5.39±2.98)%(P0.05).Tim-3 expression in CD4+T cells was significantly associated with clinicopathological features such as invasion depth,lymph node metastasis and TNM stage(P0.05).No correlation was found between Tim-3 and gender,age,tumor size and histological type(P0.05).In CD8+T cells,Tim-3 expression correlated with TNM stage rather than other clinicopathological features.Conclusion Tim-3 played an important role in the invasion and metastasis of gastric cancer,and was a prognostic factor for poor outcome.
出处 《临床肿瘤学杂志》 CAS 2012年第3期219-222,共4页 Chinese Clinical Oncology
基金 国家自然科学基金资助项目(81171653 30950022 30972703) 江苏省自然科学基金资助项目(BK2011246 BK2011247) 六大人才高峰第六批资金资助项目(BRA2010037) 江苏省卫生厅医学科技发展基金资助项目(P200932 P200933)
关键词 T细胞免疫球蛋白与黏蛋白结构域分子3 流式细胞术 胃癌 T cell immunoglobulin domain and mucin domain molecule 3 Flow cytometry Gastric cancer
  • 相关文献

参考文献14

  • 1Ngiow SF,yon Scheidt B,Akiba H. Anti-TIM3 antibody promotes T cell IFN-gamma-mediated antitumor immunity and suppresses established tumors[J].Cancer Research,2011,(10):3540-3551.
  • 2Bajtai A,Hidvegi J. The role of gastric mucosal dysplasia in the development of gastric carcinoma[J].Pathology Oncology Research,1998,(04):297-300.
  • 3Sabatos CA,Chakravarti S,Cha E. Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance[J].Nature Immunology,2003,(11):1102-1110.doi:10.1038/ni988.
  • 4Sanchez-Fueyo A,Tian J,Picarella D. Tim-3 inhibits T helper type 1-mediated auto-and alloimmune responses and promotes immunological tolerance[J].Nature Immunology,2003,(11):1093-1101.
  • 5Zhu C,Anderson AC,Schubart A. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity[J].Nature Immunology,2005,(12):1245-1252.doi:10.1038/ni1271.
  • 6Simmons WJ,Koneru M,Mohindru M. Tim-3 + T-bet +tumor-specific Th1 cells colocalize with and inhibit development and growth of murine neoplasms[J].Journal of Immunology,2005,(03):1405-1415.
  • 7Hu WK,Lu XX,Yang S. Expression of the Th1-specific cell-surface protein Tim-3 increases in a murine model of atopic asthma[J].Journal of Asthma,2009,(09):872-877.
  • 8Wu QW,Cai PC,Wang L. Family-based association study of Tim-1 and Tim-3 gene polymorphisms with childhood asthma in Chinese trios[J].International Archives of Allergy and Applied Immunology,2009,(03):252-260.
  • 9Van de Weyer PS,Muehlfeit M,Klose C. A highly conserved tyrosine of Tim-3 is phosphorylated upon stimulation by its ligand galectin-9[J].Biochemical and Biophysical Research Communications,2006,(02):571-576.
  • 10Huang X,Bai X,Cao Y. Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progression of lymphoma by mediating immune evasion[J].Journal of Experimental Medicine,2010,(03):505-520.

二级参考文献10

  • 1Kennedy R,Celis E.Multiple roles for CD4^+ T cells in anti-tumor immune responses.Immunol Rev,2008,222:129-144.
  • 2Bajtai A,Hidvegi J.The role of gastric mucosal dysplasia in the development of gastric carcinorna.Pathol Oncol Res,1998,4:297-300.
  • 3Pages F,Berger A,Camus M,et al.Effector memory T cells,early metastasis,and survival in colorectal cancer.N Engl J Med,2005,353:2654-2666.
  • 4Hershberg RM,Mayer LF.Antigen processing and presentation by intestinal epithelial cells-polarity and complexity.Immunol Today,2000,21:123-128.
  • 5Suciu-Foca N,Manavalan JS,Cortesini R.Generation and function of antigen-specific suppressor and regulatory T cells.Transpl Immunol,2003,11:235-244.
  • 6Hamanishi J,Mandai M,Iwasaki M,et al.Programmed cell death 1ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer.Proc Natl Acad Sci USA,2007,104:3360-3365.
  • 7Jiang J,Zhu Y,Wu C,et al.Tumor expression of B7-H4 predicts poor survival of patients suffering from gastric cancer.Cancer Immunol Immunother,2010,59:1707-1714.
  • 8Wu C,Zhu Y,Jiang J,et al.Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance.Acta Histochem,2006,108:19-24.
  • 9蒋敬庭,吴昌平,沈月平,朱一蓓,陈陆俊,孙静,胡文蔚,孔炯,吴鸿雅,Lu Binfeng,张学光.共刺激分子B7-H4在胃癌组织中表达及其与预后的关系[J].中华实验外科杂志,2009,26(9):1155-1158. 被引量:29
  • 10蒋敬庭,吴昌平,沈月平,郑璐,吴骏,季枚,郑晓,吴雨岗,朱一蓓,LU Bin-feng,张学光.协同刺激分子B7-H4影响细胞因子诱导的杀伤细胞治疗胃癌预后的多因素COX模型分析[J].中华实验外科杂志,2010,27(5):656-660. 被引量:16

共引文献9

同被引文献63

  • 1陈孝平,张万广.肝细胞性肝癌实验研究的热点与展望[J].中华实验外科杂志,2006,23(3):264-265. 被引量:19
  • 2王启明,李肖,贾连群,杨开明,周鸿鹰,羊惠君.Wnt/β-catenin信号通路在实验性大鼠肝癌形成过程中的作用[J].细胞与分子免疫学杂志,2006,22(4):454-457. 被引量:11
  • 3张唯,蔡荣,张红峰,钱程.肿瘤干细胞[J].生命的化学,2006,26(6):498-500. 被引量:3
  • 4许朝旭,张桂梅,黄波,冯作化.膜型Tim-3分子促进荷瘤小鼠抗肿瘤免疫应答的研究[J].医学分子生物学杂志,2007,4(3):200-203. 被引量:6
  • 5Jemal A, Siegel R, Xu J, et al. Cancer statistics [J]. CA Can- cer J Clin, 2010,60(5) :277 -300.
  • 6Sugiyama Y, Masumori N, Fukuta F, et al. Influence of isoflavone intake and equol-producing intestinal flora on prostate cancer risk [J]. Asian Pac J Cancer Prey, 2013, 14( 1 ) : 1-4.
  • 7Xu LW, Qian M, Jia RP, et al. Expression and significance of microsomal prostaglandin synthasc-I (mPGES-1) and Beclin-I in the development of prostate cancer [J]. Asian Pac J Cancer Prey, 2012, 13(4) : 1639-1644.
  • 8Zhuang X, Zhang X, Xia X, et al. Eetopie expression of TIM-3 in lung eaneers: a potential independenl prognostie factor for patients with NSCLC [J]. Am J Clin Pathnl, 2012, 137(6) :978 -985.
  • 9Wiener Z, Kohalmi B, Pocza P, et al. TIM-3 is expressed in melanoma cells and is upregulated in TGF-beta stimulated mast cells [J]. J Invest Dermalol, 2007, 127(4) :906-914.
  • 10Sakuishi K, Apetoh L, Sullivan JM, et al. Targeting TIM-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tu- mor immunity [j]. J Exp Med, 2010, 207(10) :2187-2194.

引证文献8

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部